Promius Pharma an affiliate of Dr Reddy's Laboratories and Valeant Pharmaceuticals International Inc. jointly announced that they has signed a collaboration agreement for Cloderm (clocortolone pivalate 0.1 per cent) cream.

Under the agreement, Promius Pharma will make an upfront payment and pay future royalties as the consideration for the right to manufacture, distribute and market Cloderm cream in US, effectively immediately. The financial terms and conditions of the agreement have not been disclosed.

Raghav Chari, PhD, senior vice president, Proprietary Products and Head of Promius Pharma, said, “We are very pleased to have formed a partnership with Valeant to market Cloderm cream in the United States, where Promius Pharma is building a strong commercial and clinical presence. Cloderm cream is a time-tested product and has strong recognition among dermatologists. The addition of this product will bolster our ongoing efforts to build a successful prescription branded franchise in the US, and specifically contribute to Promius' goal to become a leader in the field of medical dermatology.”

Cloderm (clocortolone pivalate) cream, 0.1 per cent is a topical mid potent steroid product indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Cloderm cream is available in a 45-gram and 90-gram tube, and in a 30-gram or 75-gram pump, by prescription only.

The most common adverse events associated with Cloderm cream include dryness, irritation, folliculitis, itching, and burning. It is contraindicated in patients who are hypersensitive to any of the ingredients of this product. As with all topical corticosteroids, systemic absorption can produce reversible HPA-axis suppression.

Promius Pharma, is a branded specialty company and a wholly-owned subsidiary of Dr. Reddy's Laboratories, Inc. and aims to be a leading-edge company that develops and markets innovative solutions for challenging dermatological conditions with an eye to the future to redefine therapeutic options for physicians and patients.

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.